These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 1430232)

  • 1. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.
    Shimano H; Yamada N; Katsuki M; Yamamoto K; Gotoda T; Harada K; Shimada M; Yazaki Y
    J Clin Invest; 1992 Nov; 90(5):2084-91. PubMed ID: 1430232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ; van 't Hof HB; Mol MJ; van der Boom H; van der Zee A; Frants RR; Hofker MH; Havekes LM
    J Clin Invest; 1996 Mar; 97(5):1184-92. PubMed ID: 8636429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
    Venkatesan N; Devaraj SN; Devaraj H
    Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
    Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
    van Vlijmen BJ; Pearce NJ; Bergö M; Staels B; Yates JW; Gribble AD; Bond BC; Hofker MH; Havekes LM; Groot PH
    Arzneimittelforschung; 1998 Apr; 48(4):396-402. PubMed ID: 9608883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects.
    Rubinsztein DC; Cohen JC; Berger GM; van der Westhuyzen DR; Coetzee GA; Gevers W
    J Clin Invest; 1990 Oct; 86(4):1306-12. PubMed ID: 2212015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice.
    Shimano H; Namba Y; Ohsuga J; Kawamura M; Yamamoto K; Shimada M; Gotoda T; Harada K; Yazaki Y; Yamada N
    J Clin Invest; 1994 May; 93(5):2215-23. PubMed ID: 8182153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.
    Shachter NS; Ebara T; Ramakrishnan R; Steiner G; Breslow JL; Ginsberg HN; Smith JD
    J Clin Invest; 1996 Aug; 98(3):846-55. PubMed ID: 8698877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol metabolism in rat is affected by protocatechuic acid.
    Tamura A; Fukushima M; Shimada K; Han KH; Sekikawa M; Watanabe S; Nakano M; Matsumoto M; Chiji H; ;
    J Nutr Sci Vitaminol (Tokyo); 2004 Feb; 50(1):13-8. PubMed ID: 15228212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.
    Fan J; Ji ZS; Huang Y; de Silva H; Sanan D; Mahley RW; Innerarity TL; Taylor JM
    J Clin Invest; 1998 May; 101(10):2151-64. PubMed ID: 9593771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice.
    van Vlijmen BJ; Mensink RP; van 't Hof HB; Offermans RF; Hofker MH; Havekes LM
    J Lipid Res; 1998 Jun; 39(6):1181-8. PubMed ID: 9643349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes.
    Goldberg IJ; Hu Y; Noh HL; Wei J; Huggins LA; Rackmill MG; Hamai H; Reid BN; Blaner WS; Huang LS
    Diabetes; 2008 Jun; 57(6):1674-82. PubMed ID: 18346984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.
    Linton MF; Hasty AH; Babaev VR; Fazio S
    J Clin Invest; 1998 Apr; 101(8):1726-36. PubMed ID: 9541504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor interactions controlling lipoprotein metabolism.
    Weisgraber KH; Innerarity TL; Rall SC; Mahley RW
    Can J Biochem Cell Biol; 1985 Aug; 63(8):898-905. PubMed ID: 2998579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma carboxyl ester lipase activity modulates apolipoprotein B-containing lipoprotein metabolism in a transgenic mouse model.
    Li L; Weng W; Harrison EH; Fisher EA
    Metabolism; 2008 Oct; 57(10):1361-8. PubMed ID: 18803939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia.
    Shimano H; Yamada N; Katsuki M; Shimada M; Gotoda T; Harada K; Murase T; Fukazawa C; Takaku F; Yazaki Y
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1750-4. PubMed ID: 1542669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis.
    Post SM; de Roos B; Vermeulen M; Afman L; Jong MC; Dahlmans VE; Havekes LM; Stellaard F; Katan MB; Princen HM
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1551-6. PubMed ID: 10845871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.